Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So...

Gfe - Asset Acquisition

Medicines Contracts with Accession Option

Corrigendum: Drug Discount Contracts with Membership Option - 0071-Rvbeitr.65-2023

Exploratory Notice to Verify Supplier Uniqueness for the Supply of an Isokinetic Dynamometer

Supply of Diagnostic Material (Reagentary/Antibodies) Required for Pathological Sc Anatomy

Open House Originals Discount Agreements 2023-40 - Baricitinib

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Ambrisentan (Atc Code According to Who: C02kx02)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Flecainide (Atc Code According to Who: C01bc04)